1. All Products
  2. DORA - Oral drugs
  3. RALTEGRAVIR potassium (RAL), eq. 25mg base, chewable tab.
Public Pricelist

RALTEGRAVIR potassium (RAL), eq. 25mg base, chewable tab.

https://unicat.msf.org/cat/product/69812
NST DORARALT2TC

Valid Article

6.4.2.4 - Integrase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AJ01
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

RALTEGRAVIR (RAL)

Non-standard item

Please always consider the MSF STD (dolutegravir) before ordering a NST.

Therapeutic Action

Antiretroviral, Integrase Strand Transfer Inhibitor (INSTI)

Indications

Raltegravir is no longer first-line Integrase Strand Transfer Inhibitor (INSTI) per WHO guidelines.

Dolutegravir is the preferred option as component of third-line Anti-Retroviral Therapy (ART) regimens in ART-experienced HIV patients.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

It is recommended to use combinations of 3 or 4 antiretroviral medicines.

Dolutegravir 10 mg or 50 mg tablets are preferred.

Storage

Below 25ºC - Protect from humidity